9/11/2009 11:07:35 AM
ORANGE COUNTY, Calif. (Sept. 3, 2009) - Beckman Coulter, Inc. and Propel Labs, LLC., have entered into a new strategic alliance for flow cytometry. As part of this alliance, Propel will support Beckman Coulter with field upgrades of MoFlo instruments to the specifications associated with the more recent XDP version.
“Customers that have MoFlo systems are extremely loyal to the product and have been for many years.” said Brad Calvin, vice president of Beckman Coulter's Flow Cytometry Business Center. “This alliance demonstrates our continued support for these customers and a product that has become central to their research applications.”
“We’re very pleased to provide the XDP upgrade to MoFlo customers and to be aligned with Beckman Coulter,” said Matt Ottenberg, CEO and founder of Propel Labs. “This reinforces the vision of a modular, scalable and upgradeable MoFlo platform."
About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits and operating-type lease payments, represents approximately 78 percent of the company's 2008 annual revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.
About Propel Labs
Propel Labs, LLC, based in Fort Collins, Colorado is a privately held bio-instrumentation development company with in-depth expertise in flow cytometry. Propel Labs delivers rapid time to market bio-instrumentation systems to ensure maximum return on investment for our customers. For more information, visit www.propel-labs.com.
Beckman Coulter and the stylized logo are registered trademarks of Beckman Coulter, Inc. MoFlo is a trademark of Beckman Coulter, Inc.
comments powered by